Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation

J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):720-725. doi: 10.1097/MPG.0000000000002894.

Abstract

Objectives: Since 2005, a New Wilson Index (NWI) ≥11 is used as a predictor of death without transplantation in fulminant Wilson disease (WD). Plasma exchange is advocated as a new treatment modality.

Methods: We present a patient with fulminant WD treated with plasma exchange. All published cases applying plasma exchange for fulminant WD were reviewed systematically.

Results: A 14-year-old girl presented with hemolysis and fulminant liver failure. She had no encephalopathy; NWI was 14. As a bridge to transplantation plasma exchange was started immediately. Complete remission was achieved with plasma exchange and later chelation therapy with D-penicillamine. She is now at 3-year transplant-free survival. Literature review identified 37 patients presenting with fulminant WD and NWI ≥11 who were treated with plasma exchange. Seventeen of these patients (ie, 46%) recovered without transplantation.

Conclusions: Multiple case reports and case series demonstrate transplant free survival after plasma exchange and subsequent chelation therapy, despite a NWI ≥11. Plasma exchange affects the clinical course and is a therapeutic option in children and young adults presenting with fulminant WD.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Child
  • Female
  • Hepatolenticular Degeneration* / therapy
  • Humans
  • Liver Failure, Acute* / therapy
  • Liver Transplantation*
  • Penicillamine
  • Plasma Exchange*
  • Young Adult

Substances

  • Penicillamine